191 related articles for article (PubMed ID: 21904591)
1. The diagnosis and treatment of endometrial cancer: progress and controversies.
Denschlag D; Ulrich U; Emons G
Dtsch Arztebl Int; 2010 Aug; 108(34-35):571-7. PubMed ID: 21904591
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; Colombo A; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Carinelli S; Provencher D; Hanzen C; Lutgens LCHW; Smit VTHBM; Singh N; Do V; D'Amico R; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189
[TBL] [Abstract][Full Text] [Related]
3. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
4. The nature of early-stage endometrial cancer recurrence-A national cohort study.
Jeppesen MM; Jensen PT; Gilså Hansen D; Iachina M; Mogensen O
Eur J Cancer; 2016 Dec; 69():51-60. PubMed ID: 27816832
[TBL] [Abstract][Full Text] [Related]
5. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
[TBL] [Abstract][Full Text] [Related]
6. Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group study.
Gemer O; Segev Y; Helpman L; Hag-Yahia N; Eitan R; Raban O; Vaknin Z; Leytes S; Ben Arie A; Amit A; Levy T; Namazov A; Volodarsky M; Ben Shachar I; Atlas I; Bruchim I; Lavie O
Am J Obstet Gynecol; 2018 Aug; 219(2):181.e1-181.e6. PubMed ID: 29792852
[TBL] [Abstract][Full Text] [Related]
7. Role of adjuvant chemotherapy in patients with FIGO stage IB grade 3 endometrial endometrioid adenocarcinoma treated with surgery and post-operative radiotherapy.
Reshko LB; Gaskins JT; Dryden SM; Metzinger DS; Todd SL; Eldredge-Hindy HB; Silva SR
Int J Gynecol Cancer; 2021 May; 31(5):694-701. PubMed ID: 33741653
[TBL] [Abstract][Full Text] [Related]
8. A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma.
Alimena S; Fiascone S; Krasner C; King M; Horowitz N
Curr Probl Cancer; 2019 Oct; 43(5):443-449. PubMed ID: 30770127
[TBL] [Abstract][Full Text] [Related]
9. Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?
Plante M; Stanleigh J; Renaud MC; Sebastianelli A; Grondin K; Grégoire J
Gynecol Oncol; 2017 Aug; 146(2):240-246. PubMed ID: 28577885
[TBL] [Abstract][Full Text] [Related]
10. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
11. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
Xu MJ; Chu C; Rubin S; Lin LL
Am J Clin Oncol; 2017 Dec; 40(6):598-604. PubMed ID: 26237194
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.
Narayan K; Khaw P; Bernshaw D; Mileshkin L; Kondalsamy-Chennakesavan S
Int J Gynecol Cancer; 2012 Feb; 22(2):260-6. PubMed ID: 22080878
[TBL] [Abstract][Full Text] [Related]
13. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
[TBL] [Abstract][Full Text] [Related]
14. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
15. Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee.
Shigeta S; Nagase S; Mikami M; Ikeda M; Shida M; Sakaguchi I; Ushioda N; Takahashi F; Yamagami W; Yaegashi N; Udagawa Y; Katabuchi H
J Gynecol Oncol; 2017 Nov; 28(6):e76. PubMed ID: 29027394
[TBL] [Abstract][Full Text] [Related]
16. The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group study.
Namazov A; Gemer O; Helpman L; Hag-Yahia N; Eitan R; Raban O; Vaknin Z; Leytes S; Lavie O; Amit A; Levy T; Volodarsky M; Ben Shachar I; Atlas I; Bruchim I; Ben-Arie A
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():120-124. PubMed ID: 31689674
[TBL] [Abstract][Full Text] [Related]
17. Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients.
Eggink FA; Mom CH; Boll D; Ezendam NPM; Kruitwagen RFPM; Pijnenborg JMA; van der Aa MA; Nijman HW
Gynecol Oncol; 2017 Aug; 146(2):380-385. PubMed ID: 28552255
[TBL] [Abstract][Full Text] [Related]
18. Improving oncologic outcomes for women with endometrial cancer: realigning our sights.
Dowdy SC
Gynecol Oncol; 2014 May; 133(2):370-4. PubMed ID: 24561031
[TBL] [Abstract][Full Text] [Related]
19. Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancer.
Nakayama K; Nagai Y; Ishikawa M; Aoki Y; Miyazaki K
Int J Clin Oncol; 2010 Oct; 15(5):440-6. PubMed ID: 20419386
[TBL] [Abstract][Full Text] [Related]
20. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]